Join
Live feed
·
PRReleasevia Quantisnow
Vistagen Therapeutics Inc. logo

VistaGen Therapeutics to Report Fiscal Year 2023 First Quarter Financial Results on August 11, 2022

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTGN (Vistagen Therapeutics Inc.) and more on Quantisnow.